Annual Accounts Payable
$602.90 K
-$2.26 M-78.91%
December 31, 2023
Summary
- As of February 7, 2025, SLRX annual accounts payable is $602.90 thousand, with the most recent change of -$2.26 million (-78.91%) on December 31, 2023.
- During the last 3 years, SLRX annual accounts payable has fallen by -$1.25 million (-67.48%).
- SLRX annual accounts payable is now -78.91% below its all-time high of $2.86 million, reached on December 31, 2022.
Performance
SLRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$165.80 K
-$477.30 K-74.22%
September 30, 2024
Summary
- As of February 7, 2025, SLRX quarterly accounts payable is $165.80 thousand, with the most recent change of -$477.30 thousand (-74.22%) on September 30, 2024.
- Over the past year, SLRX quarterly accounts payable has dropped by -$548.20 thousand (-76.78%).
- SLRX quarterly accounts payable is now -95.28% below its all-time high of $3.51 million, reached on March 31, 2023.
Performance
SLRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SLRX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.9% | -76.8% |
| 3 y3 years | -67.5% | -92.8% |
| 5 y5 years | +76.0% | -92.8% |
SLRX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.9% | at low | -95.3% | at low |
| 5 y | 5-year | -78.9% | at low | -95.3% | at low |
| alltime | all time | -78.9% | +76.0% | -95.3% | at low |
Salarius Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $165.80 K(-74.2%) |
| Jun 2024 | - | $643.10 K(-9.9%) |
| Mar 2024 | - | $714.00 K(+18.4%) |
| Dec 2023 | $602.90 K(-78.9%) | $602.90 K(-44.6%) |
| Sep 2023 | - | $1.09 M(-52.4%) |
| Jun 2023 | - | $2.29 M(-34.9%) |
| Mar 2023 | - | $3.51 M(+22.8%) |
| Dec 2022 | $2.86 M(+85.2%) | $2.86 M(+66.5%) |
| Sep 2022 | - | $1.72 M(-8.4%) |
| Jun 2022 | - | $1.87 M(+10.7%) |
| Mar 2022 | - | $1.69 M(+9.7%) |
| Dec 2021 | $1.54 M(-16.8%) | $1.54 M(+25.0%) |
| Sep 2021 | - | $1.23 M(-3.2%) |
| Jun 2021 | - | $1.28 M(-18.9%) |
| Mar 2021 | - | $1.57 M(-15.1%) |
| Dec 2020 | $1.85 M(+3.5%) | $1.85 M(+55.1%) |
| Sep 2020 | - | $1.20 M(+3.9%) |
| Jun 2020 | - | $1.15 M(+17.4%) |
| Mar 2020 | - | $979.80 K(-45.3%) |
| Dec 2019 | $1.79 M | $1.79 M(+9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $1.64 M(+104.0%) |
| Jun 2019 | - | $805.50 K(+332.4%) |
| Mar 2019 | - | $186.30 K(-45.6%) |
| Dec 2018 | $342.50 K(-82.9%) | $342.50 K(-73.2%) |
| Sep 2018 | - | $1.28 M(+11.7%) |
| Jun 2018 | - | $1.15 M(-48.9%) |
| Mar 2018 | - | $2.24 M(+11.8%) |
| Dec 2017 | $2.00 M(+68.1%) | $2.00 M(+118.1%) |
| Sep 2017 | - | $919.00 K(-49.1%) |
| Jun 2017 | - | $1.81 M(+120.6%) |
| Mar 2017 | - | $818.80 K(-31.3%) |
| Dec 2016 | $1.19 M(+36.2%) | $1.19 M(-5.1%) |
| Sep 2016 | - | $1.26 M(-18.6%) |
| Jun 2016 | - | $1.54 M(+0.2%) |
| Mar 2016 | - | $1.54 M(+76.0%) |
| Dec 2015 | $875.60 K(+51.3%) | $875.60 K(+26.4%) |
| Sep 2015 | - | $692.70 K(-14.7%) |
| Jun 2015 | - | $812.30 K(+43.0%) |
| Mar 2015 | - | $567.90 K(+61.1%) |
| Dec 2014 | $578.70 K | - |
| Sep 2014 | - | $352.60 K |
FAQ
- What is Salarius Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual accounts payable year-on-year change?
- What is Salarius Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly accounts payable year-on-year change?
What is Salarius Pharmaceuticals annual accounts payable?
The current annual accounts payable of SLRX is $602.90 K
What is the all time high annual accounts payable for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual accounts payable is $2.86 M
What is Salarius Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, SLRX annual accounts payable has changed by -$2.26 M (-78.91%)
What is Salarius Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of SLRX is $165.80 K
What is the all time high quarterly accounts payable for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly accounts payable is $3.51 M
What is Salarius Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, SLRX quarterly accounts payable has changed by -$548.20 K (-76.78%)